Houston—Co-working company WeWork is opening its latest “Labs” space in Houston.
New York-based WeWork, which has 49 Labs programs across the United States and globe, opened its first Texas location, in Dallas, last fall. WeWork’s Labs is the business’s version... Read more »
Austin—[Updated 10:10 a.m. See below.] Magnitude Software is selling a $179 million stake in the company to London-based private equity firm 3i Group.
Chris Ney, the founder, chairman, and CEO of Magnitude, is investing alongside 3i, the company... Read more »
Flipside Crypto, a Boston startup developing analytics for cryptocurrencies, has landed its main metric onto CoinMarketCap and other financial websites including MarketWatch, TheStreet and Stocktwits, the company says.
Founded in 2017, Flipside says its Fundamental Crypto Asset Score—FCAS for short—rates the... Read more »
Dallas—AmplifAI Solutions, which makes artificial intelligence-enabled software for call center operations, has raised $3.9 million.
Investors in the funding round were Dallas-based Naya Ventures, and LiveOak Venture Partners and Capital Factory, both in Austin.
AmplifAI has developed software that uses... Read more »
An experimental drug developed by Dermira to treat atopic dermatitis has hit the main goal of its mid-stage study, helping to build a case that the injectable treatment could measure up against a drug from Regeneron Pharmaceuticals and Sanofi.
Atopic dermatitis... Read more »
Houston—Tom Luby, the head of JLabs in Houston, has been named the new director of the Texas Medical Center’s Innovation Institute, the center announced Monday morning.
Luby takes over the innovation institute three months after former director Erik Halvorsen left... Read more »
Igneous, a Seattle-based data-storage startup that manages servers and other on-premise computing equipment for its customers, announced on Friday $25 million in new financing.
WestRiver Group, an investment firm collaborative based in Kirkland, WA, led the Series C funding round, Igneous... Read more »
A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA.
CureMatch was... Read more »